Cargando…
High dose intensity combination chemotherapy for advanced epithelial ovarian carcinoma: results of a pilot study.
Retrospective studies have recently demonstrated a significant correlation between dose intensity of chemotherapy and response rates and survival in various diseases including epithelial ovarian carcinoma. As part of a proposed randomised trial to assess the effect of dose intensity on outcome in ov...
Autores principales: | Sweetenham, J. W., McKendrick, J. J., Jones, D. H., Whitehouse, J. M., Williams, C. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971386/ https://www.ncbi.nlm.nih.gov/pubmed/2155645 |
Ejemplares similares
-
Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment.
por: Sweetenham, J. W., et al.
Publicado: (1989) -
Dose intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel with peripheral blood progenitor cell support for six cycles in advanced epithelial ovarian cancer
por: Barlow, C, et al.
Publicado: (2004) -
Trials in advanced Hodgkin's disease: asking the right questions at the right time
por: Sweetenham, J
Publicado: (2001) -
Implications of an overview of chemotherapy in advanced ovarian carcinoma.
por: Williams, C. J.
Publicado: (1992) -
High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer.
por: Ferguson, J. E., et al.
Publicado: (1993)